Annual report
7140.TEDINET S100TQXY
Period2023-04-01 → 2024-03-31
Filed2024-06-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 147
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥9.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥10.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥9.7bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥9.5bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.1bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥247m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥236m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥241m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥230m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥153m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥113m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥23m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥241m | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥230m | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥172m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥153m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥105m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥71m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥15m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥172m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥153m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥3.3bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥3.1bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥2.5bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥2.3bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥2.1bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.2bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥2.1bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.1bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥935m | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥455m | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥349m | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥278m | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥901m | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥844m | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥901m | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥844m | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥783m | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥862m | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥852m | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥163m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥244m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥221m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥243m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥58m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥3m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥12m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥6m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥16m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥15m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥103m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥317m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥148m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥216m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥313m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥93.13 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.78 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥87.89 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.46 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.89 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥88.2 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥84.24 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥604.81 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥507.75 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥380.2 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥292.01 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥232.55 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 34.1% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.4% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.3% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 15.2% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 13.0% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 16.7% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 22.1% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 26.1% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 22.7% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 52 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 52 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 53 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 54 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 47 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥9.5bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥10.0bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥9.7bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥9.5bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥8.1bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥195m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥231m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥190m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥225m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥130m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥101m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥17m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥190m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥225m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥140m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥149m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥89m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥62m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥11m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥3.2bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥3.0bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥2.4bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.3bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.1bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.1bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥2.1bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.1bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥895m | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥419m | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥330m | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥267m | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥799m | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥742m | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥75.66 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥83.2 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.7 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.14 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.09 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥71.66 | 2023-04-01 → 2024-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥81.71 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥565.79 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥485.96 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥350.47 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥275.48 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥223.33 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 33.1% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.7% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.1% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 14.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 12.6% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 14.4% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.6% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 23.9% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 20.9% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.4% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,857,800 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,842,300 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,196,200 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,981 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,981 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 52 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 52 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 53 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 54 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 47 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pet Healthcare Businessreportable segment | employees | at 2024-03-31 | 52 pure |
| Pet Healthcare Businessreportable segment | employees | at 2024-03-31 | 52 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,078
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | Prior1YearInstant | 3075734000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant | 3299529000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 232.55 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 292.01 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 380.20 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 507.75 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 604.81 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 12.89 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 59.46 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 87.89 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 85.78 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 93.13 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 84.24 | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | 88.20 | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.130 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.152 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.183 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.304 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.341 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | 0.060 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | 0.227 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.261 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.221 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.167 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 19.3 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 9.7 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | -58484000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | 242550000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | -220673000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | -244264000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 163470000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | 14758000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -15648000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -6360000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -11883000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -3237000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | -313275000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | -216474000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | 147959000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 317322000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | -102860000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 851533000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 861961000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant | 782886000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |